Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18

1.

Smoking, use of moist snuff, and risk of chronic inflammatory diseases.

Carlens C, Hergens MP, Grunewald J, Ekbom A, Eklund A, Höglund CO, Askling J.

Am J Respir Crit Care Med. 2010 Jun 1;181(11):1217-22. doi: 10.1164/rccm.200909-1338OC. Epub 2010 Mar 4.

PMID:
20203245
2.

Epidemiologic perspectives on smokeless tobacco marketing and population harm.

Tomar SL.

Am J Prev Med. 2007 Dec;33(6 Suppl):S387-97. Review.

PMID:
18021914
3.

Smokeless tobacco: a gateway to smoking or a way away from smoking.

Melikian AA, Hoffmann D.

Biomarkers. 2009 Jul;14 Suppl 1:85-9. doi: 10.1080/13547500902965401. Review.

PMID:
19604066
4.

A qualitative and quantitative risk assessment of snuff dipping.

Nilsson R.

Regul Toxicol Pharmacol. 1998 Aug;28(1):1-16. Review. Erratum in: Regul Toxicol Pharmacol 1999 Feb;29(1):97.

PMID:
9784428
5.

Snuffing out cigarette sales and the smoking deaths epidemic.

Laugesen M.

N Z Med J. 2007 Jun 15;120(1256):U2587. Review.

PMID:
17589555
6.

Smokeless tobacco and oral cancer: a review of the risks and determinants.

Rodu B, Jansson C.

Crit Rev Oral Biol Med. 2004 Sep 1;15(5):252-63. Review.

PMID:
15470264
7.
8.

Effect of smokeless tobacco (snus) on smoking and public health in Sweden.

Foulds J, Ramstrom L, Burke M, Fagerström K.

Tob Control. 2003 Dec;12(4):349-59. Review.

9.

Health risks related to dual use of cigarettes and snus - a systematic review.

Lee PN.

Regul Toxicol Pharmacol. 2014 Jun;69(1):125-34. doi: 10.1016/j.yrtph.2013.10.007. Epub 2013 Oct 31. Review.

10.

Systematic review of the relation between smokeless tobacco and cancer in Europe and North America.

Lee PN, Hamling J.

BMC Med. 2009 Jul 29;7:36. doi: 10.1186/1741-7015-7-36. Review.

11.

The effect on health of switching from cigarettes to snus - a review.

Lee PN.

Regul Toxicol Pharmacol. 2013 Jun;66(1):1-5. doi: 10.1016/j.yrtph.2013.02.010. Epub 2013 Feb 26. Review.

12.

[Tobacco, snuff and oral health].

Heikkinen AM, Meurman JH, Sorsa T.

Duodecim. 2015;131(21):1975-80. Review. Finnish.

PMID:
26677547
13.

Electrical disturbance in heart by smokeless tobacco.

Puri A, Chaudhary G, Srivastava R, Tiwari S.

J Assoc Physicians India. 2013 May;61(5):332-4. Review.

PMID:
24482946
14.

Multiple sclerosis and inflammatory bowel diseases: a systematic review and meta-analysis.

Kosmidou M, Katsanos AH, Katsanos KH, Kyritsis AP, Tsivgoulis G, Christodoulou D, Giannopoulos S.

J Neurol. 2017 Feb;264(2):254-259. doi: 10.1007/s00415-016-8340-8. Epub 2016 Nov 22. Review.

PMID:
27878439
15.

The effect of smoking on intestinal inflammation: what can be learned from animal models?

Verschuere S, De Smet R, Allais L, Cuvelier CA.

J Crohns Colitis. 2012 Feb;6(1):1-12. doi: 10.1016/j.crohns.2011.09.006. Epub 2011 Oct 12. Review.

16.

Evaluation of in vitro assays for assessing the toxicity of cigarette smoke and smokeless tobacco.

Johnson MD, Schilz J, Djordjevic MV, Rice JR, Shields PG.

Cancer Epidemiol Biomarkers Prev. 2009 Dec;18(12):3263-304. doi: 10.1158/1055-9965.EPI-09-0965. Review.

17.

[Smoking and alimentary diseases].

Tsujii M, Iijima H, Nishida T, Takehara T.

Nihon Rinsho. 2013 Mar;71(3):436-42. Review. Japanese.

PMID:
23631231
18.

[Smoking and multiple sclerosis].

Arruti M, Castillo-Triviño T, Egüés N, Olascoaga J.

Rev Neurol. 2015 Feb 16;60(4):169-78. Review. Spanish.

PMID:
25670047

Supplemental Content

Support Center